In June Cancer Council NSW awarded over $5 million in funding for 12 new, world-class cancer research projects.
‘The outstanding and innovative cancer researchers from across Australia are leading the charge towards a cancer free future by investigating new ways to diagnose and treat the disease.’
Follow the links below to learn more about each project:
- Targeting cellular plasticity to prevent and treat chemotherapy resistant disease – Dr Beatriz Perez San Juan, The Garvan Institute of Medical Research
- Overcoming a major treatment challenge in advanced prostate cancer – Professor Jeff Holst, UNSW Sydney
- Designing a targeted treatment for aggressive lung cancer – Associate Professor Thomas Cox, The Garvan Institute of Medical Research
- Targeting childhood cancer where it begins – Professor Murray Norris, Children’s Cancer Institute
- Developing an immunotherapy for triple negative breast cancer – Associate Professor David Gallego Ortega, University of Technology Sydney
- Improving outcomes for a devastating childhood leukaemia – Professor Richard Lock, Children’s Cancer Institute
- Developing personalised treatments for pancreatic cancer – Associate Professor Marina Pajic, The Garvan Institute of Medical Research
- Protein Biosignatures for Predicting Recurrence of Stage II Colorectal Cancer – Dr Seong Beom Ahn, Macquarie University
- Extending the benefit of immunotherapy for child with solid cancers – Dr Klaartje Somers, Children’s Cancer Institute
- Harnessing androgen-mediated viral mimicry to improve immunotherapy in prostate cancer – Associate Professor Luke Selth, Flinders University
- Engineering childhood cancer for precision medicine – Professor Maria Kavallaris, Children’s Cancer Institute
- Leveraging stem-like memory T cells for effective anti-cancer mRNA vaccines – Associate Professor Joanna Groom, The Walter and Eliza Hall Institute of Medical Research
